Long-Acting Injection
Showing 1 - 25 of >10,000
Implementation and Delivery of Cabotegravir Long Acting
Not yet recruiting
- HIV Infections
- Cabotegravir Injection [Apretude]
-
Seattle, Washington
- +1 more
May 16, 2023
Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,
Not yet recruiting
- Advanced Gastroenteropancreatic Neuroendocrine Tumor
- Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide
- long-acting Octreotide.
- (no location specified)
May 22, 2023
Cisgender Female Patients Who Start on Long Acting Cabotegravir
Not yet recruiting
- Hiv
- Cabotegravir Injection [Apretude]
-
Orlando, Florida
- +2 more
Nov 17, 2023
Abilify Maintena + Rexult in Schizophrenia
Recruiting
- Schizophrenia and Related Disorders
- Anxiety Depression
- ARIPiprazole Injection [Abilify]
- Brexpiprazole
-
Hong Kong, Hong KongQueen Mary Hospital
Mar 9, 2022
HIV Trial in Glendale (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir extended release suspension for injection
Completed
- HIV Infections
- Cabotegravir Tablets
- +3 more
-
Glendale, CaliforniaGSK Investigational Site
Feb 14, 2022
Schizophrenia Trial in Long Beach, Marlton (Lumateperone Long-Acting Injectable)
Recruiting
- Schizophrenia
- Lumateperone Long-Acting Injectable
-
Long Beach, California
- +1 more
Apr 7, 2022
Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once
Recruiting
- Primary Progressive Multiple Sclerosis
- GA Depot 40mg once monthly
- GA Depot 25mg once monthly
-
Haifa, Israel
- +6 more
Oct 30, 2022
Oregon PrEP at Home Study
Not yet recruiting
- HIV/AIDS
- Cabotegravir Injection
-
Portland, OregonOregon Health & Science University
Jul 15, 2023
Urologic Diseases, Hypospadias, Undescended Testes Trial in Baltimore (Exparel 133 MG Per 10 ML Injection, Bupivacaine
Recruiting
- Urologic Diseases
- +5 more
- Exparel 133 miligrams per 10 milliliter injection
- Bupivacaine Hydrochloride
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 13, 2022
Schizophrenia Trial in Korea, Republic of (abilify maintena)
Completed
- Schizophrenia
- abilify maintena
-
Busan, Korea, Republic of
- +4 more
Jan 25, 2021
HIV Trial in New Zealand, United States (Cabotegravir sodium (Oral Lead In), Cabotegravir 400 mg/mL, Cabotegravir 200 mg/mL)
Recruiting
- HIV Infections
- Cabotegravir sodium (Oral Lead In)
- +6 more
-
Orlando, Florida
- +4 more
Mar 29, 2022
Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Tablet, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil
Not yet recruiting
- Pre-Exposure Prophylaxis of HIV Infection
- Lenacapavir Tablet
- +2 more
- (no location specified)
Oct 20, 2023
Human Immunodeficiency Virus, Contraception, ART Trial in Gaborone (Dolutegravir, Levonorgestrel implant, Depo
Recruiting
- Human Immunodeficiency Virus
- +2 more
- Dolutegravir
- +2 more
-
Gaborone, BotswanaPrincess Marina Hospital
Mar 1, 2022
Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Injection, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil
Not yet recruiting
- Pre-Exposure Prophylaxis of HIV Infection
- Lenacapavir Injection
- +2 more
- (no location specified)
Oct 20, 2023
Bunion Trial in Salt Lake City (Local anesthetic injection of CPL-01, Naropin, 0.5% Injectable Solution, Placebo)
Not yet recruiting
- Bunion
- Local anesthetic injection of CPL-01
- +2 more
-
Salt Lake City, UtahTodd Bertoch
Apr 25, 2023
HIV Trial in Rio De Janeiro (Cabotegravir Injection)
Not yet recruiting
- HIV Infections
- Cabotegravir Injection
-
Rio De Janeiro, BrazilInstituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
Aug 23, 2022
Multiple Sclerosis Trial in Ashkelon, Haifa, Tel Aviv (GA Depot 80 mg, GA Depot 40 mg)
Active, not recruiting
- Multiple Sclerosis
- GA Depot 80 mg
- GA Depot 40 mg
-
Ashkelon, Israel
- +2 more
Aug 9, 2021
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)
Completed
- Schizophrenia
- +4 more
- Abilify maintena
-
Chungju, Chungcheongbuk-do, Korea, Republic of
- +26 more
Dec 16, 2021
Acute Pain Trial in Hong Kong (Bupivacaine Injection [Marcaine], Bupivacaine Liposome 13.3 MG/ML [Exparel])
Recruiting
- Acute Pain
- Bupivacaine Injection [Marcaine]
- Bupivacaine Liposome 13.3 MG/ML [Exparel]
-
Hong Kong, Hong KongThe University of Hong Kong
Dec 8, 2021
HIV Trial (CAB LA)
Not yet recruiting
- HIV Infections
- CAB LA
- (no location specified)
Nov 21, 2023
Diabetes, Type 2 Trial in Minneapolis, Berlin, Toronto (4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short))
Terminated
- Diabetes Mellitus, Type 2
- 4 mm x 32G pen needle (Nano)
- 8mm x 31G pen needle (Short)
-
Minneapolis, Minnesota
- +2 more
Feb 28, 2022